Skip to main content
PMC home page
Virologica Sinica logoLink to Virologica Sinica
. 2014 Jan 20;29(1):17–24. doi: 10.1007/s12250-014-3412-3

Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies

Jieliang Chen 1, Zhenghong Yuan 1,✉
PMCID: PMC8206324  PMID: 24452540

Abstract

Hepatitis B virus (HBV) infection is still a worldwide health problem; however, the current antiviral therapies for chronic hepatitis B are limited in efficacy. The outcome of HBV infection is thought to be the result of complex interactions between the HBV and the host immune system. While the role of the adaptive immune responses in the resolution of HBV infection has been well characterized, the contribution of innate immune mechanisms remains elusive until recent evidence implicates that HBV appears to activate the innate immune response and this response is important for controlling HBV infection. Here, we review our current understanding of innate immune responses to HBV infection and the multifaceted evasion by the virus and discuss the potential strategies to combat chronic HBV infection via induction and restoration of host innate antiviral responses.

Keywords: HBV, innate immunity, viral evasion, interferon, antiviral approaches

References

  1. Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo G, Dandri M, Levrero M. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest. 2012;122:529–537. doi: 10.1172/JCI58847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61:1754–1764. doi: 10.1136/gutjnl-2011-301073. [DOI] [PubMed] [Google Scholar]
  3. Chang J, Block T M, Guo J T. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. Antiviral Res. 2012;96:405–413. doi: 10.1016/j.antiviral.2012.10.001. [DOI] [PubMed] [Google Scholar]
  4. Chen J, Zhang W, Lin J, Wang F, Wu M, Chen C, Zheng Y, Peng X, Li J, Yuan Z. Mol Ther. 2013. An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen J, Wu M, Zhang X, Zhang W, Zhang Z, Chen L, He J, Zheng Y, Chen C, Wang F, Hu Y, Zhou X, Wang C, Xu Y, Lu M, Yuan Z. Hepatitis B virus polymerase impairs interferon-alpha-induced STA T activation through inhibition of importin-alpha5 and protein kinase C-delta. Hepatology. 2013;57:470–482. doi: 10.1002/hep.26064. [DOI] [PubMed] [Google Scholar]
  6. Chen Y, Cheng G, Mahato R I. RNAi for treating hepatitis B viral infection. Pharm Res. 2008;25:72–86. doi: 10.1007/s11095-007-9504-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen Z, Cheng Y, Xu Y, Liao J, Zhang X, Hu Y, Zhang Q, Wang J, Zhang Z, Shen F, Yuan Z. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol. 2008;128:400–408. doi: 10.1016/j.clim.2008.04.006. [DOI] [PubMed] [Google Scholar]
  8. Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, Morisaki T, Hada T. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1. J Hepatol. 2005;43:465–471. doi: 10.1016/j.jhep.2005.02.033. [DOI] [PubMed] [Google Scholar]
  9. Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, Heim M H. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol. 2007;81:159–165. doi: 10.1128/JVI.01292-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper A, Tal G, Lider O, Shaul Y. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol. 2005;175:3165–3176. doi: 10.4049/jimmunol.175.5.3165. [DOI] [PubMed] [Google Scholar]
  11. Cradick T J, Keck K, Bradshaw S, Jamieson A C, McCaffrey A P. Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther. 2010;18:947–954. doi: 10.1038/mt.2010.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar R M, Brown D, Gilson R J, Tedder R J, Dusheiko G M, Jacobs M, Klenerman P, Maini M K. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology. 2009;137:1289–1300. doi: 10.1053/j.gastro.2009.06.054. [DOI] [PubMed] [Google Scholar]
  13. Ebert G, Poeck H, Lucifora J, Baschuk N, Esser K, Esposito I, Hartmann G, Protzer U. 5′ Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology. 2011;141:696–706. doi: 10.1053/j.gastro.2011.05.001. [DOI] [PubMed] [Google Scholar]
  14. Fernandez M, Quiroga J A, Carreno V. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol. 2003;84:2073–2082. doi: 10.1099/vir.0.18966-0. [DOI] [PubMed] [Google Scholar]
  15. Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut. 2009;58:974–982. doi: 10.1136/gut.2008.163600. [DOI] [PubMed] [Google Scholar]
  16. Foster G R, Ackrill A M, Goldin R D, Kerr I M, Thomas H C, Stark G R. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci U S A. 1991;88:2888–2892. doi: 10.1073/pnas.88.7.2888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gordien E, Rosmorduc O, Peltekian C, Garreau F, Brechot C, Kremsdorf D. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol. 2001;75:2684–2691. doi: 10.1128/JVI.75.6.2684-2691.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gruffaz M, Testoni B, Luangsay S, Ait-Goughoulte M, Petit M-A, Ma H, Klumpp K, Javanbakht H, Durantel D, Zoulim F. 378 hepatitis B core (hbc) protein is a key and very early negative regulator of the interferon response. Journal of Hepatology. 2013;58:S155–S156. doi: 10.1016/S0168-8278(13)60380-3. [DOI] [Google Scholar]
  19. Guidotti L G, Rochford R, Chung J, Shapiro M, Purcell R, Chisari F V. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999;284:825–829. doi: 10.1126/science.284.5415.825. [DOI] [PubMed] [Google Scholar]
  20. Guidotti L G, Morris A, Mendez H, Koch R, Silverman R H, Williams B R, Chisari F V. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol. 2002;76:2617–2621. doi: 10.1128/JVI.76.6.2617-2621.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Guo H, Jiang D, Ma D, Chang J, Dougherty A M, Cuconati A, Block T M, Guo J T. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol. 2009;83:847–858. doi: 10.1128/JVI.02008-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Guy C S, Mulrooney-Cousins P M, Churchill N D, Michalak T I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol. 2008;82:8579–8591. doi: 10.1128/JVI.01022-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Han Q, Zhang C, Zhang J, Tian Z. Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition. PLoS One. 2011;6:e27931. doi: 10.1371/journal.pone.0027931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Han Q, Zhang C, Zhang J, Tian Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology. 2011;54:1179–1189. doi: 10.1002/hep.24505. [DOI] [PubMed] [Google Scholar]
  25. Han Q, Zhang C, Zhang J, Tian Z. The role of innate immunity in HBV infection. Semin Immunopathol. 2013;35:23–38. doi: 10.1007/s00281-012-0331-y. [DOI] [PubMed] [Google Scholar]
  26. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, Tedjokusumo R, Esser K, Arzberger S, Kirschning C J, Langenkamp A, Falk C, Buning H, Rose-John S, Protzer U. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50:1773–1782. doi: 10.1002/hep.23226. [DOI] [PubMed] [Google Scholar]
  27. Isogawa M, Robek M D, Furuichi Y, Chisari F V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79:7269–7272. doi: 10.1128/JVI.79.11.7269-7272.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kosinska A D, Zhang E, Johrden L, Liu J, Seiz P L, Zhang X, Ma Z, Kemper T, Fiedler M, Glebe D, Wildner O, Dittmer U, Lu M, Roggendorf M. Combination of DNA prime-adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model. PLoS Pathog. 2013;9:e1003391. doi: 10.1371/journal.ppat.1003391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kumar M, Jung S Y, Hodgson A J, Madden C R, Qin J, Slagle B L. Hepatitis B Virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol. 2011;85:987–995. doi: 10.1128/JVI.01825-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kwon H, Lok A S. Hepatitis B therapy. Nat Rev Gastroenterol Hepatol. 2011;8:275–284. doi: 10.1038/nrgastro.2011.33. [DOI] [PubMed] [Google Scholar]
  31. Lan P, Zhang C, Han Q, Zhang J, Tian Z. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Hepatology. 2013;58:73–85. doi: 10.1002/hep.26339. [DOI] [PubMed] [Google Scholar]
  32. Lanford R E, Guerra B, Chavez D, Giavedoni L, Hodara V L, Brasky K M, Fosdick A, Frey C R, Zheng J, Wolfgang G, Halcomb R L, Tumas D B. GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. Gastroenterology. 2013;144:1508–1517. doi: 10.1053/j.gastro.2013.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol. 2011;55:762–769. doi: 10.1016/j.jhep.2010.12.042. [DOI] [PubMed] [Google Scholar]
  34. Li J, Lin S, Chen Q, Peng L, Zhai J, Liu Y, Yuan Z. Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs. J Virol. 2010;84:6387–6399. doi: 10.1128/JVI.00236-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li J, Liu K, Liu Y, Xu Y, Zhang F, Yang H, Liu J, Pan T, Chen J, Wu M, Zhou X, Yuan Z. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat Immunol. 2013;14:793–803. doi: 10.1038/ni.2647. [DOI] [PubMed] [Google Scholar]
  36. Lu H L, Liao F. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication. J Immunol. 2013;191:3264–3276. doi: 10.4049/jimmunol.1300512. [DOI] [PubMed] [Google Scholar]
  37. Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology. 2009;51:63–72. doi: 10.1002/hep.23230. [DOI] [PubMed] [Google Scholar]
  38. Lutgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann J H, Pollok J M, Lohse A W, Petersen J, Dandri M. Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice. Gastroenterology. 2011;140:2074–2083. doi: 10.1053/j.gastro.2011.02.057. [DOI] [PubMed] [Google Scholar]
  39. Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block T M, Guo J T, Guo H. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013;9:e1003494. doi: 10.1371/journal.ppat.1003494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Meng Z, Xu Y, Wu J, Tian Y, Kemper T, Bleekmann B, Roggendorf M, Yang D, Lu M. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J Virol Methods. 2008;150:27–33. doi: 10.1016/j.jviromet.2008.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Muller C, Zielinski C C. Impaired lipopolysaccharide-inducible tumor necrosis factor production in vitro by peripheral blood monocytes of patients with viral hepatitis. Hepatology. 1990;12:1118–1124. doi: 10.1002/hep.1840120507. [DOI] [PubMed] [Google Scholar]
  42. Nguyen D H, Gummuluru S, Hu J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol. 2007;81:4465–4472. doi: 10.1128/JVI.02510-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nguyen D H, Ludgate L, Hu J. Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol. 2008;216:289–294. doi: 10.1002/jcp.21416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Op den Brouw M L, Binda R S, van Roosmalen M H, Protzer U, Janssen H L, van der Molen R G, Woltman A M. Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology. 2009;126:280–289. doi: 10.1111/j.1365-2567.2008.02896.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pagliaccetti N E, Chu E N, Bolen C R, Kleinstein S H, Robek M D. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology. 2010;401:197–206. doi: 10.1016/j.virol.2010.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Protzer U, Maini M K, Knolle P A. Living in the liver: hepatic infections. Nat Rev Immunol. 2012;12:201–213. doi: 10.1038/nri3169. [DOI] [PubMed] [Google Scholar]
  47. Rang A, Gunther S, Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J Hepatol. 1999;31:791–799. doi: 10.1016/S0168-8278(99)80279-7. [DOI] [PubMed] [Google Scholar]
  48. Revill P, Yuan Z. New insights into how HBV manipulates the innate immune response to establish acute and persistent infection. Antivir Ther. 2013;18:1–15. doi: 10.3851/IMP2542. [DOI] [PubMed] [Google Scholar]
  49. Robek M D, Boyd B S, Chisari F V. Lambda interferon inhibits hepatitis B and C virus replication. J Virol. 2005;79:3851–3854. doi: 10.1128/JVI.79.6.3851-3854.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science. 2004;303:1829. doi: 10.1126/science.1092066. [DOI] [PubMed] [Google Scholar]
  51. Vincent I E, Zannetti C, Lucifora J, Norder H, Protzer U, Hainaut P, Zoulim F, Tommasino M, Trepo C, Hasan U, Chemin I. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One. 2011;6:e26315. doi: 10.1371/journal.pone.0026315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Visvanathan K, Skinner N A, Thompson A J, Riordan S M, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45:102–110. doi: 10.1002/hep.21482. [DOI] [PubMed] [Google Scholar]
  53. Wang H, Ryu W S. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 2010;6:e1000986. doi: 10.1371/journal.ppat.1000986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wang Q, Zhou J, Zhang B, Tian Z, Tang J, Zheng Y, Huang Z, Tian Y, Jia Z, Tang Y, van Velkinburgh J C, Mao Q, Bian X, Ping Y, Ni B, Wu Y. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog. 2013;9:e1003410. doi: 10.1371/journal.ppat.1003410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wang S, Chen Z, Hu C, Qian F, Cheng Y, Wu M, Shi B, Chen J, Hu Y, Yuan Z. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation. J Immunol. 2013;190:5142–5151. doi: 10.4049/jimmunol.1201625. [DOI] [PubMed] [Google Scholar]
  56. Wei C, Ni C, Song T, Liu Y, Yang X, Zheng Z, Jia Y, Yuan Y, Guan K, Xu Y, Cheng X, Zhang Y, Wang Y, Wen C, Wu Q, Shi W, Zhong H. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol. 2010;185:1158–1168. doi: 10.4049/jimmunol.0903874. [DOI] [PubMed] [Google Scholar]
  57. Wieland S, Thimme R, Purcell R H, Chisari F V. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A. 2004;101:6669–6674. doi: 10.1073/pnas.0401771101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wieland S F, Guidotti L G, Chisari F V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol. 2000;74:4165–4173. doi: 10.1128/JVI.74.9.4165-4173.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G, Schlaak J F. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology. 2007;46:1769–1778. doi: 10.1002/hep.21897. [DOI] [PubMed] [Google Scholar]
  60. Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa J P, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak J F. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology. 2009;49:1132–1140. doi: 10.1002/hep.22751. [DOI] [PubMed] [Google Scholar]
  61. Xu Y, Hu Y, Shi B, Zhang X, Wang J, Zhang Z, Shen F, Zhang Q, Sun S, Yuan Z. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol. 2009;46:2640–2646. doi: 10.1016/j.molimm.2009.04.031. [DOI] [PubMed] [Google Scholar]
  62. Yu S, Chen J, Wu M, Chen H, Yuan Z. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol. 2010;91:2080–2090. doi: 10.1099/vir.0.020552-0. [DOI] [PubMed] [Google Scholar]
  63. Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, Bosse E, Iqbal J, Hussain M M, Balschun K, Rocken C, Arlt A, Gunther R, Hampe J, Schreiber S, Baron J L, Moody D B, Liang T J, Blumberg R S. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med. 2012;18:1060–1068. doi: 10.1038/nm.2811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak J F, Roggendorf M, Lu M. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. J Hepatol. 2012;57:522–528. doi: 10.1016/j.jhep.2012.05.004. [DOI] [PubMed] [Google Scholar]
  65. Zimmerman K A, Fischer K P, Joyce M A, Tyrrell D L. Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J Virol. 2008;82:8013–8021. doi: 10.1128/JVI.00366-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zoulim F. Are novel combination therapies needed for chronic hepatitis B? Antiviral Res. 2012;96:256–259. doi: 10.1016/j.antiviral.2012.09.006. [DOI] [PubMed] [Google Scholar]

Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES